Living donor liver transplantation: is the hype over?

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis Wichit Srikureja,

Volume 61, Issue 6, Pages (December 2014)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Immigration and viral hepatitis

Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Outcomes Among Living Liver Donors

Volume 66, Issue 1, Pages 1-4 (January 2017)

What lessons have we learned in pediatric liver transplantation?

Reply to: “DCD consensus and futility in liver transplantation”

Volume 44, Pages S19-S24 (January 2006)

The place of downstaging for hepatocellular carcinoma

Mauro Bernardi, Stefano Gitto, Maurizio Biselli Journal of Hepatology

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Quality measurement and improvement in liver transplantation

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Age and liver transplantation

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Volume 70, Issue 1, Pages (January 2019)

Chetana Lim, Chady Salloum, Daniel Azoulay

Immigration and viral hepatitis

The potential of induced pluripotent stem cell derived hepatocytes

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Volume 51, Issue 2, Pages (August 2009)

The use of hemospray in portal hypertensive bleeding; a case series

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Jingzhi Cai, Wengang Guo, Chuangye.

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Donor-recipient matching: Myths and realities

Chimeric mouse model of hepatitis B virus infection

Volume 44, Issue 1, Pages (January 2006)

Comment on the article “Age and liver transplantation”

Genetics of hepatocellular carcinoma: The next generation

MELD: the holy grail of organ allocation?

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Volume 64, Issue 6, Pages (June 2016)

Volume 70, Issue 5, Pages (May 2019)

Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Living donor liver transplantation: is the hype over? James F. Trotter Journal of Hepatology Volume 42, Issue 1, Pages 20-25 (January 2005) DOI: 10.1016/j.jhep.2004.11.003 Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 1 LDLT in the United States vs. year. Journal of Hepatology 2005 42, 20-25DOI: (10.1016/j.jhep.2004.11.003) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Distribution of MELD scores for patients listed for transplant. Journal of Hepatology 2005 42, 20-25DOI: (10.1016/j.jhep.2004.11.003) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 3 MELD distribution in transplant recipients: small vs. large OPO. Journal of Hepatology 2005 42, 20-25DOI: (10.1016/j.jhep.2004.11.003) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions